Brief: Lineage Posts Quarterly Loss Per Share Of $0.05

Lineage Cell Therapeutics

10/11/2021 21:53

Nov 10 (Reuters) - Lineage Cell Therapeutics Inc  LCTX.A :
    * LINEAGE REPORTS THIRD QUARTER 2021 FINANCIAL RESULTS AND
HIGHLIGHTS PROGRESS FROM CLINICAL CELL THERAPY PROGRAMS
    * QTRLY LOSS PER SHARE $0.05
    * Q3 EARNINGS PER SHARE VIEW $-0.05 -- REFINITIV IBES DATA

Source text for Eikon:  ID:nBw6JcjgJa 
Further company coverage:  LCTX.A 

 ((Reuters.Briefs@thomsonreuters.com;))